Connor, Clark & Lunn Investment Management »

Kymera Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.7M 104k 83.29

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Toronto Dominion Bk Ont Com New (TD)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Apple (AAPL)
Shopify Cl A Sub Vtg Shs (SHOP)
Bk Nova Cad (BNS)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Canadian Pacific Kansas City (CP)
Microsoft Corporation (MSFT)
Amazon (AMZN)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
BVF
BlackRock
Atlas Venture Life Science Advisors
Wellington Management Company
Siren
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management

View all funds holding Kymera Therapeutics